Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cryolife (CRY)

Cryolife (CRY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cryolife 1655 Roberts Boulevard N.W Kennesaw GA 30144 USA

P: 770-419-3355 F: 770-590-3753

Description:

CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries. It operates throughout the U.S. and internationally. CryoLife manufactures and distributes BioGlue Surgical Adhesive, an FDA-approved adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in Europe for use in soft tissue repair and has received additional marketing approvals in several other countries throughout the world. CryoLife's BioFoam Surgical Matrix is CE marked in Europe for use as an adjunct to hemostasis in cardiovascular surgery and on abdominal parenchymal tissues (liver and spleen) when control of bleeding by ligature or conventional methods is ineffective or impractical. CryoLife distributes PerClot, a powdered hemostat, in Europe and other select international countries.

Key Statistics

Overview:

Market Capitalization, $K 666,722
Shares Outstanding, K 39,081
Annual Sales, $ 276,220 K
Annual Net Income, $ 1,720 K
Last Quarter Sales, $ 66,440 K
Last Quarter Net Income, $ -3,650 K
60-Month Beta 1.21
% of Insider Shareholders 4.40%
% of Institutional Shareholders 75.04%
Float, K 37,361
% Float 95.60%

Growth:

1-Year Return -42.67%
3-Year Return 7.30%
5-Year Return 64.67%
5-Year Revenue Growth 90.97%
5-Year Earnings Growth 72.22%
5-Year Dividend Growth -100.00%

Per-Share Information:

Most Recent Earnings 0.10 on 02/13/20
Next Earnings Date 05/05/20
Earnings Per Share ttm 0.31
EPS Growth vs. Prev Qtr 66.67%
EPS Growth vs. Prev Year 100.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 0.030 on 12/09/15
Next Ex-Dividends Date 12/09/15
Dividend Payable Date 12/18/15
Dividend Payout Ratio 0.00
Most Recent Split 3-2 on 12/28/00

CRY Ratios

Ratio
Price/Earnings ttm 53.13
Price/Earnings forward 107.26
Price/Earnings to Growth 58.82
Return-on-Equity % 4.16%
Return-on-Assets % 1.96%
Profit Margin % 0.62
Net Margin % 2.19
Debt/Equity 0.83
Price/Sales 2.33
Price/Cash Flow 20.59
Price/Book 2.16
Book Value/Share 7.62
Interest Coverage -1.11
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar